{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:07:15Z","timestamp":1792112835094,"version":"4.4.0"},"reference-count":239,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017815","name":"American College of Chest Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017815","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.chest.2015.11.026","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T04:15:58Z","timestamp":1452140158000},"page":"315-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4231,"title":["Antithrombotic Therapy for VTE Disease"],"prefix":"10.1016","volume":"149","author":[{"given":"Clive","family":"Kearon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Blaivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Bounameaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine R.E.","family":"Vintch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Woller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Moores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u00a0Suppl","key":"10.1016\/j.chest.2015.11.026_bib1","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.chest.2015.11.026_bib2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-152-11-201006010-00254","article-title":"The vexing problem of guidelines and conflict of interest: a potential solution","volume":"152","author":"Guyatt","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.chest.2015.11.026_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.chest.2015.11.026_bib4","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3.\u00a0Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","article-title":"Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force","volume":"129","author":"Guyatt","year":"2006","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5.\u00a0Rating the quality of evidence\u2014publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib9","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence\u2014imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7.\u00a0Rating the quality of evidence\u2014inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8.\u00a0Rating the quality of evidence\u2014indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9.\u00a0Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1.\u00a0Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14.\u00a0Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib15","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation\u2014determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"2\u00a0Suppl","key":"10.1016\/j.chest.2015.11.026_bib16","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.11-2290","article-title":"Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"MacLean","year":"2012","journal-title":"Chest"},{"issue":"7001","key":"10.1016\/j.chest.2015.11.026_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.14-0824","article-title":"Methodologies for the development of CHEST guidelines and expert panel reports","volume":"146","author":"Lewis","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.chest.2015.11.026_bib19","doi-asserted-by":"crossref","first-page":"a744","DOI":"10.1136\/bmj.a744","article-title":"Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive","volume":"337","author":"Jaeschke","year":"2008","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.chest.2015.11.026_bib20","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.chest.2015.11.026_bib21","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.9243","article-title":"Tinzaparin vs\u00a0Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: a randomized clinical trial","volume":"314","author":"Lee","year":"2015","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.chest.2015.11.026_bib23","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Buller","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.chest.2015.11.026_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.chest.2015.11.026_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Buller","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib27","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.thromres.2014.06.020","article-title":"Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis","volume":"134","author":"Gomez-Outes","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.chest.2015.11.026_bib30","doi-asserted-by":"crossref","first-page":"e7498","DOI":"10.1136\/bmj.e7498","article-title":"Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials","volume":"345","author":"Fox","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"12","author":"van der Hulle","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11239-014-1102-5","article-title":"Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism","volume":"39","author":"Mantha","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"15","key":"10.1016\/j.chest.2015.11.026_bib33","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood-2014-07-590323","article-title":"The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis","volume":"124","author":"Chai-Adisaksopha","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2014.10.033","article-title":"Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention","volume":"135","author":"Wu","year":"2015","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.chest.2015.11.026_bib35","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jama.2014.10538","article-title":"Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis","volume":"312","author":"Castellucci","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib36","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.thromres.2014.09.039","article-title":"Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis","volume":"134","author":"Carrier","year":"2014","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1378\/chest.14-0402","article-title":"Direct oral anticoagulants in patients with vte and cancer: a systematic review and meta-analysis","volume":"147","author":"Vedovati","year":"2015","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib38","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/jth.12746","article-title":"Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: comment","volume":"12","author":"Di Minno","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.thromres.2015.02.024","article-title":"Cancer-associated thrombosis: investigating the role of new oral anticoagulants","volume":"135","author":"Franchini","year":"2015","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1160\/TH11-08-0565","article-title":"The treatment of venous thromboembolism with low-molecular-weight heparins. A meta-analysis","volume":"107","author":"Bochenek","year":"2012","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib41","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.amjcard.2013.11.049","article-title":"Meta-analysis of randomized controlled trials on the risk of bleeding with dabigatran","volume":"113","author":"Bloom","year":"2014","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.amjcard.2014.11.039","article-title":"A\u00a0meta-analysis of randomized controlled trials of the risk of bleeding with apixaban versus vitamin K antagonists","volume":"115","author":"Touma","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.chest.2015.11.026_bib43","doi-asserted-by":"crossref","first-page":"h1857","DOI":"10.1136\/bmj.h1857","article-title":"Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study","volume":"350","author":"Abraham","year":"2015","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib44","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.thromres.2014.03.035","article-title":"Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism","volume":"133","author":"Kang","year":"2014","journal-title":"Thromb Res"},{"issue":"21","key":"10.1016\/j.chest.2015.11.026_bib45","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.113.002332","article-title":"Management and outcomes of major bleeding during treatment with dabigatran or warfarin","volume":"128","author":"Majeed","year":"2013","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","article-title":"Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism","volume":"349","author":"Kearon","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib48","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2015.11.026_bib49","doi-asserted-by":"crossref","first-page":"f5133","DOI":"10.1136\/bmj.f5133","article-title":"Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis","volume":"347","author":"Castellucci","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib50","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.thromres.2015.02.032","article-title":"Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: a network meta-analysis","volume":"135","author":"Sobieraj","year":"2015","journal-title":"Thromb Res"},{"issue":"19","key":"10.1016\/j.chest.2015.11.026_bib51","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","article-title":"Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review","volume":"170","author":"Iorio","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.chest.2015.11.026_bib52","doi-asserted-by":"crossref","first-page":"d3036","DOI":"10.1136\/bmj.d3036","article-title":"Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials","volume":"342","author":"Boutitie","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib53","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients","volume":"92","author":"Prandoni","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib55","first-page":"805","article-title":"A\u00a0comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy","volume":"84","author":"Palareti","year":"2000","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.chest.2015.11.026_bib56","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/j.1538-7836.2010.04022.x","article-title":"Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient level meta-analysis","volume":"8","author":"Baglin","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib57","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","article-title":"Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors","volume":"160","author":"Hansson","year":"2000","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1016\/j.chest.2015.11.026_bib58","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa030104","article-title":"Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran","volume":"349","author":"Schulman","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"32","key":"10.1016\/j.chest.2015.11.026_bib59","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1200\/JCO.2013.51.7433","article-title":"Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study","volume":"32","author":"Napolitano","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2015.7046","article-title":"Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: The PADIS-PE randomized clinical trial","volume":"314","author":"Couturaud","year":"2015","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib61","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A\u00a0comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.chest.2015.11.026_bib62","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa035029","article-title":"Long-term, low-intensity warfarin therapy for prevention of recurrent venous thromboembolism","volume":"348","author":"Ridker","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib63","first-page":"848","article-title":"Anticoagulation period in idiopathic venous thromboembolism. How long is enough?","volume":"25","author":"Farraj","year":"2004","journal-title":"Saudi Med J"},{"issue":"17","key":"10.1016\/j.chest.2015.11.026_bib64","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1056\/NEJMoa054444","article-title":"D-dimer testing to determine the duration of anticoagulation therapy","volume":"355","author":"Palareti","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","article-title":"The duration of oral anticoagulant therapy after a second episode of venous thromboembolism","volume":"336","author":"Schulman","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2015.11.026_bib66","doi-asserted-by":"crossref","first-page":"d813","DOI":"10.1136\/bmj.d813","article-title":"Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis","volume":"342","author":"Douketis","year":"2011","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib67","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/0003-4819-153-8-201010190-00009","article-title":"Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability\u00a0of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism","volume":"153","author":"Douketis","year":"2010","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib68","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","article-title":"D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study","volume":"124","author":"Palareti","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/M14-1275","article-title":"D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study","volume":"162","author":"Kearon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.chest.2015.11.026_bib70","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.chest.2015.11.026_bib71","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.chest.2015.11.026_bib72","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","article-title":"Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration","volume":"130","author":"Simes","year":"2014","journal-title":"Circulation"},{"issue":"2\u00a0suppl","key":"10.1016\/j.chest.2015.11.026_bib73","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","article-title":"Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Ninth Edition)","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1160\/TH05-08-0588","article-title":"Clinical relevance of distal deep vein thrombosis. Review of literature data","volume":"95","author":"Righini","year":"2006","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib75","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.disamonth.2010.06.011","article-title":"The case for managing calf vein thrombi with duplex surveillance and selective anticoagulation","volume":"56","author":"Masuda","year":"2010","journal-title":"Dis Mon"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib76","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jvs.2011.05.092","article-title":"The controversy of managing calf vein thrombosis","volume":"55","author":"Masuda","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jvs.2011.09.087","article-title":"A\u00a0meta-analysis of anticoagulation for calf deep venous thrombosis","volume":"56","author":"De Martino","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-011-0670-x","article-title":"Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study","volume":"33","author":"Spencer","year":"2012","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib79","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.thromres.2014.09.036","article-title":"Silent pulmonary embolism in patients with distal deep venous thrombosis: systematic review","volume":"134","author":"Hughes","year":"2014","journal-title":"Thromb Res"},{"issue":"23\u00a0suppl 1","key":"10.1016\/j.chest.2015.11.026_bib80","first-page":"I22","article-title":"Natural history of venous thromboembolism","volume":"107","author":"Kearon","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib81","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1067\/mva.2003.149","article-title":"Short-term natural history of isolated gastrocnemius and soleal vein thrombosis","volume":"37","author":"Macdonald","year":"2003","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib82","first-page":"68","article-title":"Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study","volume":"28","author":"Parisi","year":"2009","journal-title":"Int Angiol"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib83","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood-2013-10-512616","article-title":"How I treat isolated distal deep vein thrombosis (IDDVT)","volume":"123","author":"Palareti","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib84","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/jth.12512","article-title":"Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis","volume":"12","author":"Galanaud","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib85","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jvs.2010.05.094","article-title":"Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study","volume":"52","author":"Schwarz","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/ejvs.2002.1665","article-title":"Early results of thrombolysis vs\u00a0anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial","volume":"24","author":"Elsharawy","year":"2002","journal-title":"Eur J Vasc Endovasc.Surg"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib87","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1538-7836.2009.03464.x","article-title":"Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency","volume":"7","author":"Enden","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib88","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ahj.2007.07.010","article-title":"Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis\u2014the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)","volume":"154","author":"Enden","year":"2007","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jvir.2012.09.023","article-title":"Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis","volume":"24","author":"Haig","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"9810","key":"10.1016\/j.chest.2015.11.026_bib90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"Enden","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib91","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jth.12184","article-title":"Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis","volume":"11","author":"Enden","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib92","first-page":"Cd002783","article-title":"Thrombolysis for acute deep vein thrombosis","author":"Watson","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.chest.2015.11.026_bib93","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1001\/jamainternmed.2014.3415","article-title":"Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs\u00a0anticoagulation alone to treat lower-extremity proximal deep vein thrombosis","volume":"174","author":"Bashir","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib94","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1160\/TH13-11-0932","article-title":"Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis","volume":"111","author":"Engelberger","year":"2014","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A\u00a0clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis","volume":"338","author":"Decousus","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib96","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study","volume":"112","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib97","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjmed.2013.11.003","article-title":"Vena cava filters in unstable elderly patients with acute pulmonary embolism","volume":"127","author":"Stein","year":"2014","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib98","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjmed.2011.05.025","article-title":"Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism","volume":"125","author":"Stein","year":"2012","journal-title":"Am J Med"},{"issue":"16","key":"10.1016\/j.chest.2015.11.026_bib99","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jacc.2014.01.058","article-title":"Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk","volume":"63","author":"Muriel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamainternmed.2013.2725","article-title":"The inferior vena cava filter: how could a medical device be so well accepted without any evidence of efficacy?","volume":"173","author":"Prasad","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib101","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1160\/TH13-07-0601","article-title":"Medical literature, vena cava filters and evidence of efficacy. A descriptive review","volume":"111","author":"Girard","year":"2014","journal-title":"Thromb Haemost"},{"issue":"16","key":"10.1016\/j.chest.2015.11.026_bib102","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs\u00a0anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA"},{"issue":"9054","key":"10.1016\/j.chest.2015.11.026_bib103","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(96)12215-7","article-title":"Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis","volume":"349","author":"Brandjes","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib104","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-141-4-200408170-00004","article-title":"Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial","volume":"141","author":"Prandoni","year":"2004","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.chest.2015.11.026_bib105","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","article-title":"The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"130","author":"Kahn","year":"2014","journal-title":"Circulation"},{"issue":"9920","key":"10.1016\/j.chest.2015.11.026_bib106","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(13)61902-9","article-title":"Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib107","first-page":"1137","article-title":"Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial","volume":"112","author":"Kahn","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.chest.2015.11.026_bib108","doi-asserted-by":"crossref","first-page":"f3368","DOI":"10.1136\/bmj.f3368","article-title":"When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found","volume":"347","author":"Wiener","year":"2013","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib109","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1538-7836.2010.03938.x","article-title":"Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies","volume":"8","author":"Carrier","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib110","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1538-7836.2012.04804.x","article-title":"Symptomatic subsegmental pulmonary embolism: what is the next step?","volume":"10","author":"Carrier","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1076029611422363","article-title":"Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options","volume":"18","author":"Stein","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"issue":"9","key":"10.1016\/j.chest.2015.11.026_bib112","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ajem.2008.08.019","article-title":"Interobserver agreement in the interpretation of computed tomography in acute pulmonary embolism","volume":"27","author":"Costantino","year":"2009","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib113","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2012.11.027","article-title":"Concerns in using multi-detector computed tomography for diagnosing pulmonary embolism in daily practice. A cross-sectional analysis using expert opinion as reference standard","volume":"131","author":"Lucassen","year":"2013","journal-title":"Thromb Res"},{"issue":"22","key":"10.1016\/j.chest.2015.11.026_bib114","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa052367","article-title":"Multidetector computed tomography for acute pulmonary embolism","volume":"354","author":"Stein","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1538-7836.2009.03724.x","article-title":"Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector computerized tomographic angiography for pulmonary embolism","volume":"8","author":"Courtney","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib116","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1538-7836.2011.04612.x","article-title":"Difference in interpretation of computed tomography pulmonary angiography diagnosis of subsegmental thrombosis in patients with suspected pulmonary embolism","volume":"10","author":"Pena","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib117","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1538-7836.2006.01819.x","article-title":"Diagnosis and management of subsegmental pulmonary embolism","volume":"4","author":"Le Gal","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib118","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1160\/TH06-03-0158","article-title":"A\u00a0positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients","volume":"95","author":"Le Gal","year":"2006","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib119","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood-2013-04-497545","article-title":"Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism","volume":"122","author":"den Exter","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib120","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.7326\/0003-4819-129-12-199812150-00009","article-title":"The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism","volume":"129","author":"Kearon","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib121","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.thromres.2009.09.026","article-title":"Home treatment in pulmonary embolism","volume":"126","author":"Otero","year":"2010","journal-title":"Thromb Res"},{"issue":"9785","key":"10.1016\/j.chest.2015.11.026_bib122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(11)60824-6","article-title":"Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial","volume":"378","author":"Aujesky","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib123","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.thromres.2013.08.012","article-title":"Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis","volume":"132","author":"Piran","year":"2013","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib124","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.annemergmed.2012.05.041","article-title":"Can selected patients with newly diagnosed pulmonary embolism be safely treated without hospitalization? A systematic review","volume":"60","author":"Vinson","year":"2012","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1183\/09031936.00093712","article-title":"Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis","volume":"42","author":"Zondag","year":"2013","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib126","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1538-7836.2010.03888.x","article-title":"The validation and reproducibility of the pulmonary embolism severity index","volume":"8","author":"Chan","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"15","key":"10.1016\/j.chest.2015.11.026_bib127","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","article-title":"Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism","volume":"170","author":"Jimenez","year":"2010","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1538-7836.2009.03725.x","article-title":"Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism","volume":"8","author":"Moores","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2049-6958-8-34","article-title":"Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism","volume":"8","author":"Ozsu","year":"2013","journal-title":"Multidisc Respir Medic"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib130","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/j.1538-7836.2011.04469.x","article-title":"The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism","volume":"9","author":"Righini","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1160\/TH12-07-0466","article-title":"Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism","volume":"109","author":"Zondag","year":"2013","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib132","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1378\/chest.09-0608","article-title":"Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis","volume":"136","author":"Jimenez","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib133","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1183\/09031936.00211613","article-title":"Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism","volume":"43","author":"Lankeit","year":"2014","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib134","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1183\/09031936.00147813","article-title":"Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis","volume":"43","author":"Becattini","year":"2014","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib135","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/cc10119","article-title":"The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis","volume":"15","author":"Coutance","year":"2011","journal-title":"Critical care"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib136","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1160\/TH11-06-0371","article-title":"Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous ThromboEmbolism Registry (SWIVTER)","volume":"106","author":"Spirk","year":"2011","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib137","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1378\/chest.11-1355","article-title":"A\u00a0strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism","volume":"141","author":"Lankeit","year":"2012","journal-title":"Chest"},{"issue":"43","key":"10.1016\/j.chest.2015.11.026_bib138","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.chest.2015.11.026_bib139","first-page":"CD004437","article-title":"Thrombolytic treatment for pulmonary embolism","volume":"2","author":"Dong","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"8893","key":"10.1016\/j.chest.2015.11.026_bib140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","volume":"343","year":"1994","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib141","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jth.12521","article-title":"Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3\u00a0months: multicenter double-blind, placebo-controlled randomized trial","volume":"12","author":"Kline","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib142","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate Pulmonary Embolism Treated With Thrombolysis (from the \u201cMOPETT\u201d Trial)","volume":"111","author":"Sharifi","year":"2013","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.chest.2015.11.026_bib143","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.chest.2015.11.026_bib144","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1182\/blood-2014-08-559278","article-title":"The role of thrombolytic therapy in pulmonary embolism","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/eurheartj\/ehu218","article-title":"Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis","volume":"36","author":"Marti","year":"2015","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib146","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/jth.12608","article-title":"Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis","volume":"12","author":"Nakamura","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"23","key":"10.1016\/j.chest.2015.11.026_bib147","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2014.5990","article-title":"Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis","volume":"311","author":"Chatterjee","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib148","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.thromres.2014.10.004","article-title":"Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: a meta-analysis","volume":"134","author":"Riera-Mestre","year":"2014","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib149","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","article-title":"Derivation and validation of a prognostic model for pulmonary embolism","volume":"172","author":"Aujesky","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2015.11.026_bib150","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jvir.2009.08.002","article-title":"Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques","volume":"20","author":"Kuo","year":"2009","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib151","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jvir.2011.10.012","article-title":"Endovascular therapy for acute pulmonary embolism","volume":"23","author":"Kuo","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib152","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jvs.2014.10.036","article-title":"Catheter-directed interventions for acute pulmonary embolism","volume":"61","author":"Avgerinos","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"issue":"16","key":"10.1016\/j.chest.2015.11.026_bib153","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib154","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1378\/chest.15-0119","article-title":"Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): initial results from a prospective multicenter registry","volume":"148","author":"Kuo","year":"2015","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib156","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A\u00a0Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: the SEATTLE II Study","volume":"8","author":"Piazza","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib157","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.77.2.353","article-title":"Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism","volume":"77","author":"Verstraete","year":"1988","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.chest.2015.11.026_bib158","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.chest.2015.11.026_bib159","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1164\/rccm.201011-1854CI","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"183","author":"Fedullo","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","article-title":"Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"141","author":"Mayer","year":"2011","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib161","article-title":"Pulmonary thromboendarterectomy for treatment of pulmonary hypertension (structured abstract)","year":"2012","journal-title":"Health Technol Assess Database"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib162","doi-asserted-by":"crossref","first-page":"435","DOI":"10.5761\/atcs.oa.10.01653","article-title":"Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review (structured abstract)","volume":"17","author":"Rahnavardi","year":"2011","journal-title":"Annf Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib163","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib164","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamainternmed.2013.319","article-title":"Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study","volume":"173","author":"Deano","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"19","key":"10.1016\/j.chest.2015.11.026_bib165","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/heartjnl-2012-303549","article-title":"Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension","volume":"99","author":"Andreassen","year":"2013","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib166","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1378\/chest.14-0793","article-title":"Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report","volume":"146","author":"Taichman","year":"2014","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.chest.2015.11.026_bib167","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1008740","article-title":"Clinical practice. Deep-vein thrombosis of the upper extremities","volume":"364","author":"Kucher","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib168","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0268355514568534","article-title":"Paget-Schroetter syndrome: a review and Algorithm (WASPS-IR)","volume":"30","author":"Naeem","year":"2015","journal-title":"Phlebology"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib169","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin\u00a0versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib171","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2009.03326.x","article-title":"Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients","volume":"7","author":"Carrier","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib172","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jth.12070","article-title":"International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"11","author":"Farge","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib173","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1076029606293692","article-title":"Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period","volume":"12","author":"Deitcher","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib174","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjmed.2006.03.030","article-title":"Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms","volume":"120","author":"Hull","year":"2007","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib175","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.amjmed.2008.12.023","article-title":"Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome","volume":"122","author":"Hull","year":"2009","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib176","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0037-1614412","article-title":"Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis","volume":"81","author":"Lopaciuk","year":"1999","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib177","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mva.2001.109336","article-title":"Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis","volume":"33","author":"Lopez-Beret","year":"2001","journal-title":"J\u00a0Vasc Surg"},{"issue":"15","key":"10.1016\/j.chest.2015.11.026_bib178","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","article-title":"Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study","volume":"162","author":"Meyer","year":"2002","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib179","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejvs.2008.11.030","article-title":"A\u00a0randomised open-label trial comparing long-term sub-cutaneous low-molecular-weight heparin compared with oral-anticoagulant therapy in the treatment of deep venous thrombosis","volume":"37","author":"Romera","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"9","key":"10.1016\/j.chest.2015.11.026_bib180","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3324\/haematol.13055","article-title":"Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry","volume":"93","author":"Prandoni","year":"2008","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib181","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib182","first-page":"41","article-title":"Risk factors for bleeding in patients taking coumarins","volume":"1","author":"Beyth","year":"2002","journal-title":"Curr Hematol Rep"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib183","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-9560-11-21","article-title":"Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies","volume":"11","author":"Prins","year":"2013","journal-title":"Thromb J"},{"issue":"13","key":"10.1016\/j.chest.2015.11.026_bib184","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archinte.1993.00410130073007","article-title":"Bleeding complications in oral anticoagulant therapy. An analysis of risk factors","volume":"153","author":"van der Meer","year":"1993","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib186","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archinte.166.8.853","article-title":"Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding","volume":"166","author":"Douketis","year":"2006","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib187","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.159.5.457","article-title":"Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism","volume":"159","author":"Kuijer","year":"1999","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib188","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0002-9343(90)90174-C","article-title":"A\u00a0bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy","volume":"89","author":"Landefeld","year":"1990","journal-title":"Am J Med"},{"issue":"9025","key":"10.1016\/j.chest.2015.11.026_bib189","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.chest.2015.11.026_bib190","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archinte.165.13.1527","article-title":"Risks of oral anticoagulant therapy with increasing age","volume":"165","author":"Torn","year":"2005","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib191","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0002-9343(99)00267-3","article-title":"Major bleeding after hospitalization for deep-venous thrombosis","volume":"107","author":"White","year":"1999","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib192","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1538-7836.2011.04378.x","article-title":"Bleeding risk in \u2018real world\u2019 patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort","volume":"9","author":"Olesen","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib193","doi-asserted-by":"crossref","first-page":"e0122520","DOI":"10.1371\/journal.pone.0122520","article-title":"The HAS-BLED score identifies patients with acute venous thromboembolism at high risk of major bleeding complications during the first six months of anticoagulant treatment","volume":"10","author":"Kooiman","year":"2015","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.chest.2015.11.026_bib194","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7326\/0003-4819-124-11-199606010-00004","article-title":"The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics","volume":"124","author":"Fihn","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib195","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib196","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.chest.2015.11.026_bib197","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1111\/j.1538-7836.2006.02188.x","article-title":"Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome","volume":"4","author":"Nieto","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib198","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH08-03-0193","article-title":"Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"Ruiz-Gimenez","year":"2008","journal-title":"Thrombosis and haemostasis"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib199","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1650514","article-title":"Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants","volume":"76","author":"van der Meer","year":"1996","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib200","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0037-1615599","article-title":"Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study","volume":"85","author":"Pengo","year":"2001","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib201","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A\u00a0new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib202","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1378\/chest.130.5.1390","article-title":"Development of a contemporary bleeding risk model for elderly warfarin recipients","volume":"130","author":"Shireman","year":"2006","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2015.11.026_bib203","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-118-7-199304010-00005","article-title":"Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group","volume":"118","author":"Fihn","year":"1993","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib204","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1538-7836.2010.03852.x","article-title":"Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry","volume":"8","author":"Nieto","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"17","key":"10.1016\/j.chest.2015.11.026_bib205","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","article-title":"Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis","volume":"18","author":"Hutten","year":"2000","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.chest.2015.11.026_bib206","doi-asserted-by":"crossref","first-page":"h246","DOI":"10.1136\/bmj.h246","article-title":"The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study","volume":"350","author":"Jun","year":"2015","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.chest.2015.11.026_bib207","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib208","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.thromres.2010.03.016","article-title":"Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis","volume":"125","author":"Dentali","year":"2010","journal-title":"Thromb Res"},{"issue":"18","key":"10.1016\/j.chest.2015.11.026_bib209","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199005033221802","article-title":"Heparin for 5\u00a0days as compared with 10\u00a0days in the initial treatment of proximal venous thrombosis","volume":"322","author":"Hull","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib210","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M13-1581","article-title":"Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study","volume":"161","author":"Lamberts","year":"2014","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib211","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/jth.12501","article-title":"Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis","volume":"12","author":"Castellucci","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"10.1016\/j.chest.2015.11.026_bib212","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/jth.12352","article-title":"Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin","volume":"11","author":"Burgess","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib213","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/jth.12111","article-title":"Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism","volume":"11","author":"Scherz","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2015.11.026_bib214","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/jth.12239","article-title":"The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study","volume":"11","author":"Poli","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1378\/chest.12-0608","article-title":"Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a \u201creal-world\u201d population with atrial fibrillation receiving anticoagulant therapy","volume":"143","author":"Roldan","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib216","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1160\/TH13-07-0552","article-title":"Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial","volume":"110","author":"Apostolakis","year":"2013","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib217","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1160\/TH07-04-0297","article-title":"The risk of bleeding with warfarin: a systematic review and performance analysis of clinical prediction rules","volume":"98","author":"Dahri","year":"2007","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.chest.2015.11.026_bib218","first-page":"268","article-title":"Bleeding with anticoagulation therapy\u2014who is at risk, and how best to identify such patients","volume":"102","author":"Palareti","year":"2009","journal-title":"Thromb Haemost"},{"issue":"7058","key":"10.1016\/j.chest.2015.11.026_bib219","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.313.7058.652","article-title":"Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials","volume":"313","author":"Collins","year":"1996","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.chest.2015.11.026_bib220","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.293.4.427","article-title":"Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation","volume":"293","author":"Yusuf","year":"2005","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib221","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.163.8.917","article-title":"The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism","volume":"163","author":"Wells","year":"2003","journal-title":"Arch Intern Med"},{"issue":"7595","key":"10.1016\/j.chest.2015.11.026_bib222","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.39098.583356.55","article-title":"Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial","volume":"334","author":"Campbell","year":"2007","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.chest.2015.11.026_bib223","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.103.20.2453","article-title":"Comparison of 3 and 6\u00a0months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12\u00a0weeks of therapy after isolated calf deep vein thrombosis","volume":"103","author":"Pinede","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib224","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-139-1-200307010-00008","article-title":"Extended oral anticoagulant therapy after a first episode of pulmonary embolism","volume":"139","author":"Agnelli","year":"2003","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM200107193450302","article-title":"Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators","volume":"345","author":"Agnelli","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib226","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2008-01-131656","article-title":"Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study","volume":"112","author":"Siragusa","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00277-008-0626-1","article-title":"6 versus 30\u00a0months anticoagulation for recurrent venous thrombosis in patients with high factor VIII","volume":"88","author":"Eischer","year":"2009","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.chest.2015.11.026_bib228","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-147-11-200712040-00007","article-title":"The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism","volume":"147","author":"Douketis","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.chest.2015.11.026_bib229","first-page":"CD002783","article-title":"Thrombolysis for acute deep vein thrombosis","volume":"1","author":"Watson","year":"2014","journal-title":"The Cochrane Database System Rev"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib230","doi-asserted-by":"crossref","first-page":"e002984","DOI":"10.1136\/bmjopen-2013-002984","article-title":"Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study","volume":"3","author":"Enden","year":"2013","journal-title":"BMJ Open"},{"issue":"22","key":"10.1016\/j.chest.2015.11.026_bib231","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1001\/archinte.160.22.3431","article-title":"Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3\u00a0months of anticoagulant therapy","volume":"160","author":"Douketis","year":"2000","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.chest.2015.11.026_bib232","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-149-10-200811180-00004","article-title":"Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis","volume":"149","author":"Kahn","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib233","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1358863X10380304","article-title":"Fibrinolysis for acute pulmonary embolism","volume":"15","author":"Piazza","year":"2010","journal-title":"Vasc Med"},{"issue":"1","key":"10.1016\/j.chest.2015.11.026_bib234","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.amjmed.2010.07.028","article-title":"Race, bleeding, and outcomes in STEMI patients treated with fibrinolytic therapy","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.chest.2015.11.026_bib235","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1378\/chest.08-2125","article-title":"Thrombolytic therapy for acute pulmonary embolism: a critical appraisal","volume":"135","author":"Todd","year":"2009","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.chest.2015.11.026_bib236","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.STR.31.8.1802","article-title":"Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project","volume":"31","author":"Brass","year":"2000","journal-title":"Stroke"},{"issue":"16","key":"10.1016\/j.chest.2015.11.026_bib237","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.chest.2015.11.026_bib238","first-page":"CD004437","article-title":"Thrombolytic therapy for pulmonary embolism","author":"Dong","year":"2009","journal-title":"Cochrane Database System Rev"},{"key":"10.1016\/j.chest.2015.11.026_bib239","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/PPA.S56280","article-title":"Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism","volume":"8","author":"Cao","year":"2014","journal-title":"Patient Prefer Adherence"}],"updated-by":[{"DOI":"10.1016\/j.chest.2016.08.1442","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000}}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215003359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215003359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T05:32:48Z","timestamp":1668576768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215003359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":239,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0012369215003359"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2015.11.026","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726141242.793533040","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726141242.793557693","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy for VTE Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2015.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}